Viewing nowAlkanna Tablet 30mg (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 202402844 · Approved 2024.12.03 · Insurance code 656005620
Treatment of essential hypertension
Essential hypertension refers to a state of persistently elevated blood pressure. This medication helps control blood pressure in essential hypertension, thereby maintaining heart and vascular health. Patients are advised to regularly monitor their blood pressure while using this medication and to improve lifestyle habits for enhanced efficacy. This drug also plays an important role in preventing complications arising from hypertension. Thus, it is used for the treatment of essential hypertension.
Essential hypertension Adults The recommended dose is 30 ~ 60 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, take the medicine at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect in approximately 8 weeks ~ 12 weeks. Older adults No initial dose adjustment is required for older adults 70 years of age or younger. For older adults over 70 years of age, the recommended initial dose is 30 mg once daily. (See section 9, Administration to Older Adults, under Precautions for Use.) Patients with renal impairment No dose adjustment is required for patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams daily. Patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment. Do not administer this medicine to patients with moderate to severe hepatic impairment (see section 2, Patients Who Must Not Receive This Medicine, and section 10, Administration to Patients with Hepatic Impairment, under Precautions for Use). Patients with reduced effective intravascular volume (e.g., patients taking high doses of diuretics) For patients at increased risk of hypotension, such as those with reduced effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3, Patients Who Require Caution When Receiving This Medicine, under Precautions for Use.)
The safety and efficacy in pediatric and adolescent patients 18 years of age or younger have not been established.
This medication can cause severe harm or death to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, thus it must be discontinued immediately once pregnancy is confirmed. It should not be used in patients who are allergic to any of the components of this drug, pregnant or breastfeeding women, patients on kidney dialysis, patients with moderate to severe liver dysfunction, or patients with bile duct obstruction. Particular caution is needed in patients with low blood volume or sodium, impaired kidney function, renal artery hypertension, aortic stenosis or mitral valve stenosis, and primary aldosteronism when using this medication, and they should be monitored closely. Common side effects include headache and dizziness, while less frequent symptoms may include dyspepsia, nausea, elevated liver enzyme levels, cough, muscle pain, skin rash, and erectile dysfunction. If symptoms of significantly low blood pressure or severe allergic reactions occur, consult a physician immediately, particularly if there is a rapid drop in blood pressure requiring appropriate treatment. Serum potassium levels should be monitored regularly while taking this medication, and caution should be exercised when using potassium-sparing diuretics or potassium supplements, as the risk of hyperkalemia may increase. Consult a physician or pharmacist if taking in conjunction with other antihypertensives, lithium, or non-steroidal anti-inflammatory drugs (NSAIDs) to prevent interactions. Women who are pregnant or planning to conceive, as well as breastfeeding mothers, should consult healthcare professionals before taking this medication, and it's recommended to either stop breastfeeding or discontinue this medication while nursing. Safety and efficacy in children aged under 18 have not been established, so it is advised not to use it in this population. For elderly patients, dosage adjustment is generally not necessary, but some may respond more sensitively to the drug, necessitating caution. This medication should not be administered to patients with moderate to severe liver dysfunction, as severely impaired liver function may significantly increase drug concentration. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention is required. Store this medication out of the reach of children, and it is safer and better for quality to not transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is light-sensitive and should be stored in a container that does not allow light to enter. Additionally, it is important to keep the medication at room temperature, between 1 to 30 degrees Celsius. This will help maintain the efficacy and ensure the safe use of the drug.
Light green oval-shaped film-coated tablet with rounded corners
30 tablets per bottle, 300 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Dongkuk Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.